Hayato Tada

8.0k total citations
244 papers, 4.2k citations indexed

About

Hayato Tada is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hayato Tada has authored 244 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Surgery, 97 papers in Cardiology and Cardiovascular Medicine and 60 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hayato Tada's work include Lipoproteins and Cardiovascular Health (126 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (47 papers) and Cancer, Lipids, and Metabolism (43 papers). Hayato Tada is often cited by papers focused on Lipoproteins and Cardiovascular Health (126 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (47 papers) and Cancer, Lipids, and Metabolism (43 papers). Hayato Tada collaborates with scholars based in Japan, United States and Sweden. Hayato Tada's co-authors include Masa‐aki Kawashiri, Atsushi Nohara, Masakazu Yamagishi, Hiroshi Mabuchi, Akihiro Inazu, Masayuki Takamura, Kenshi Hayashi, Jun‐ichi Takanashi, A. James Barkovich and Akihiro Nomura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Hayato Tada

224 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hayato Tada Japan 32 1.9k 1.3k 827 801 652 244 4.2k
Peter Fraunberger Austria 34 803 0.4× 535 0.4× 299 0.4× 200 0.2× 456 0.7× 142 3.0k
Yukio Yuzawa Japan 44 1.1k 0.6× 686 0.5× 299 0.4× 334 0.4× 1.7k 2.7× 199 6.7k
Federico Vázquez Spain 24 613 0.3× 172 0.1× 886 1.1× 472 0.6× 389 0.6× 78 3.5k
Richard D. Hockett United States 25 1.0k 0.5× 2.0k 1.6× 554 0.7× 328 0.4× 927 1.4× 47 4.9k
Nicolas Vuilleumier Switzerland 35 738 0.4× 662 0.5× 343 0.4× 651 0.8× 649 1.0× 172 3.8k
Jan H. von der Thüsen Netherlands 39 1.1k 0.6× 498 0.4× 185 0.2× 517 0.6× 981 1.5× 194 5.5k
M.E.I. Schipper Netherlands 31 1.3k 0.7× 628 0.5× 78 0.1× 158 0.2× 610 0.9× 88 3.6k
Roslyn B. Mannon United States 45 2.5k 1.3× 361 0.3× 169 0.2× 663 0.8× 838 1.3× 205 7.6k
Gilles Hayem France 35 1.8k 0.9× 203 0.2× 224 0.3× 465 0.6× 729 1.1× 98 4.8k
Arthur H. Cohen United States 39 1.1k 0.6× 228 0.2× 430 0.5× 381 0.5× 1.3k 2.0× 133 5.8k

Countries citing papers authored by Hayato Tada

Since Specialization
Citations

This map shows the geographic impact of Hayato Tada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hayato Tada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hayato Tada more than expected).

Fields of papers citing papers by Hayato Tada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hayato Tada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hayato Tada. The network helps show where Hayato Tada may publish in the future.

Co-authorship network of co-authors of Hayato Tada

This figure shows the co-authorship network connecting the top 25 collaborators of Hayato Tada. A scholar is included among the top collaborators of Hayato Tada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hayato Tada. Hayato Tada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tada, Hayato, Yasuaki Takeji, & Masayuki Takamura. (2025). Effects of evinacumab on high-density lipoprotein function in patients with homozygous familial hypercholesterolemia. Journal of clinical lipidology. 20(2). 428–432.
2.
Tada, Hayato, et al.. (2025). Survey on the Current Status of Perinatal Management among Women with Familial Hypercholesterolemia in Japan. Journal of Atherosclerosis and Thrombosis. 32(12). 1523–1535.
3.
Kobayashi, Junji, et al.. (2024). Familial hypercholesterolemia with special focus on Japan. Clinica Chimica Acta. 556. 117847–117847.
4.
Tada, Hayato, Hirofumi Okada, Shohei Yoshida, et al.. (2024). Impact of Genetic Testing and Sex Differences among Patients with Familial Hypercholesterolemia: The Hokuriku-plus Familial Hypercholesterolemia Registry Study. Journal of Atherosclerosis and Thrombosis. 32(7). 887–895.
5.
Ogura, Masatsune, Sachiko Okazaki, Hiroaki Okazaki, et al.. (2024). Transitional Medicine of Intractable Primary Dyslipidemias in Japan. Journal of Atherosclerosis and Thrombosis. 31(5). 501–519. 4 indexed citations
6.
Tada, Hayato, Akihiro Nomura, Atsushi Nohara, et al.. (2023). Early diagnosis and treatments in childhood are associated with better prognosis in patients with familial hypercholesterolemia. European Heart Journal. 44(Supplement_2). 1 indexed citations
7.
Tada, Hayato, Atsushi Nohara, Soichiro Usui, et al.. (2023). Validation of the 2022 Clinical Diagnostic Criteria of Familial Hypercholesterolemia in Japan. Journal of Atherosclerosis and Thrombosis. 31(5). 550–558. 3 indexed citations
8.
Tada, Hayato, et al.. (2023). Healthy lifestyle, lipoprotein (a) levels and the risk of coronary artery disease. European Journal of Clinical Investigation. 54(1). e14093–e14093. 9 indexed citations
9.
Katsuyama, Eri, Kunio Matsumoto, Kei Hirose, et al.. (2023). A case of sitosterolaemia-caused systemic large-vessel stenosis mimicking Takayasu arteritis in which FDG-PET provided a clue for the differential diagnosis. Rheumatology Advances in Practice. 7(3). rkad096–rkad096. 1 indexed citations
10.
Hayashi, Kenshi, Tadashi Nakajima, Yasutaka Kurata, et al.. (2023). Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation. EP Europace. 25(6). 2 indexed citations
11.
Tada, Hayato, Nobuko Kojima, Akihiro Nomura, et al.. (2023). Impact of Healthy Lifestyle in Patients With Familial Hypercholesterolemia. JACC Asia. 3(1). 152–160. 9 indexed citations
12.
Tada, Hayato, Nobuko Kojima, Akihiro Nomura, et al.. (2022). Impact of variants of uncertain significance of LDL receptor on phenotypes of familial hypercholesterolemia. Journal of clinical lipidology. 16(6). 863–869. 2 indexed citations
13.
14.
Tada, Hayato, Hirofumi Okada, Akihiro Nomura, et al.. (2021). Prognostic impact of cascade screening for familial hypercholesterolemia on cardiovascular events. Journal of clinical lipidology. 15(2). 358–365. 25 indexed citations
15.
Tada, Hayato, Hirofumi Okada, Atsushi Nohara, Masayuki Takamura, & Masa‐aki Kawashiri. (2021). Genetic mutations, regression of Achilles tendon thickness, and cardiovascular events among patients with familial hypercholesterolemia. Atherosclerosis. 340. 28–34. 8 indexed citations
16.
Tada, Hayato, et al.. (2020). 日本人家族性高コレステロール血症におけるLDL受容体遺伝子の病原性突然変異のカタログ【JST・京大機械翻訳】. Journal of clinical lipidology. 14(3). 346–351. 1 indexed citations
17.
18.
Tada, Hayato, Masa‐aki Kawashiri, Atsushi Nohara, et al.. (2016). LIPOPROTEIN(A) IN FAMILIAL HYPERCHOLESTEROLEMIA WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS. Journal of the American College of Cardiology. 67(13). 1896–1896. 1 indexed citations
19.
Hayashi, Kenshi, Tetsuo Konno, Noboru Fujino, et al.. (2016). Impact of Updated Diagnostic Criteria for Long QT Syndrome on Clinical Detection of Diseased Patients. JACC. Clinical electrophysiology. 2(3). 279–287. 5 indexed citations
20.
Mabuchi, Hiroshi, Atsushi Nohara, Tohru Noguchi, et al.. (2014). Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation. Atherosclerosis. 236(1). 54–61. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Fraunberger Breakdown of academic impact, for papers by Yukio Yuzawa Breakdown of academic impact, for papers by Federico Vázquez Breakdown of academic impact, for papers by Richard D. Hockett Breakdown of academic impact, for papers by Nicolas Vuilleumier Breakdown of academic impact, for papers by Jan H. von der Thüsen Breakdown of academic impact, for papers by M.E.I. Schipper Breakdown of academic impact, for papers by Roslyn B. Mannon Breakdown of academic impact, for papers by Gilles Hayem Breakdown of academic impact, for papers by Arthur H. Cohen
Rankless by CCL
2026